Vimentin is required for tumor progression and metastasis in a mouse model of non–small cell lung cancer

Vimentin is highly expressed in metastatic cancers, and its expression correlates with poor patient prognoses. However, no causal in vivo studies linking vimentin and non–small cell lung cancer (NSCLC) progression existed until now. We use three complementary in vivo models to show that vimentin is...

Descripción completa

Detalles Bibliográficos
Autores principales: Berr, Alexandra L., Wiese, Kristin, dos Santos, Gimena, Koch, Clarissa M., Anekalla, Kishore R., Kidd, Martha, Davis, Jennifer M., Cheng, Yuan, Hu, Yuan-Shih, Ridge, Karen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275760/
https://www.ncbi.nlm.nih.gov/pubmed/37161053
http://dx.doi.org/10.1038/s41388-023-02703-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275760/
https://www.ncbi.nlm.nih.gov/pubmed/37161053
http://dx.doi.org/10.1038/s41388-023-02703-9

Ejemplares similares